October 9, 2025Polskie Archiwum Medycyny WewnętrznejOpen Access

Joint association of body mass index and lipoprotein(a) with atrial fibrillation prevalence: an observational and mendelian randomization study

View Full Paper

Ask AI

Bookmark

Authors

DZDorota Zarębska‐Michaluk MBMichał Brzdęk OTOlga Tronina

Discussion

Member takes

Implication

Observational analysis reveals DAA therapy's effectiveness in reducing HCC recurrence risk, highlighting potential implications for patient management.

Key Points

DAA therapy led to a 98.2% treatment effectiveness among patients with chronic hepatitis C after liver transplantation.
During long-term follow-up, only 3 patients (5.4%) experienced hepatocellular carcinoma recurrence, indicating a lower than anticipated rate.
The median time from transplantation to initiation of DAA therapy was 19.5 months, involving a population predominantly male (70.7%).
Effective DAA treatment in OLTx patients significantly lowers risks of HCC recurrence in the transplanted liver compared to natural disease history.

Cite This Study

Zarębska‐Michaluk et al. (2025) studied this question.

synapsesocial.com/papers/68e70db290569dd607ee61db https://doi.org/10.20452/pamw.17131

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis reveals DAA therapy's effectiveness in reducing HCC recurrence risk, highlighting potential implications for patient management.